ALNY
Price
$451.96
Change
-$9.28 (-2.01%)
Updated
Sep 17, 04:59 PM (EDT)
Capitalization
60.46B
36 days until earnings call
RPTX
Price
$1.75
Change
+$0.01 (+0.57%)
Updated
Sep 17, 04:41 PM (EDT)
Capitalization
75.82M
49 days until earnings call
Interact to see
Advertisement

ALNY vs RPTX

Header iconALNY vs RPTX Comparison
Open Charts ALNY vs RPTXBanner chart's image
Alnylam Pharmaceuticals
Price$451.96
Change-$9.28 (-2.01%)
Volume$15.4K
Capitalization60.46B
Repare Therapeutics
Price$1.75
Change+$0.01 (+0.57%)
Volume$100
Capitalization75.82M
ALNY vs RPTX Comparison Chart in %
Loading...
ALNY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RPTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ALNY vs. RPTX commentary
Sep 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALNY is a Hold and RPTX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 18, 2025
Stock price -- (ALNY: $461.24 vs. RPTX: $1.74)
Brand notoriety: ALNY and RPTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ALNY: 58% vs. RPTX: 18%
Market capitalization -- ALNY: $60.46B vs. RPTX: $75.82M
ALNY [@Biotechnology] is valued at $60.46B. RPTX’s [@Biotechnology] market capitalization is $75.82M. The market cap for tickers in the [@Biotechnology] industry ranges from $100.34B to $0. The average market capitalization across the [@Biotechnology] industry is $1.89B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALNY’s FA Score shows that 1 FA rating(s) are green whileRPTX’s FA Score has 0 green FA rating(s).

  • ALNY’s FA Score: 1 green, 4 red.
  • RPTX’s FA Score: 0 green, 5 red.
According to our system of comparison, RPTX is a better buy in the long-term than ALNY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALNY’s TA Score shows that 3 TA indicator(s) are bullish while RPTX’s TA Score has 5 bullish TA indicator(s).

  • ALNY’s TA Score: 3 bullish, 5 bearish.
  • RPTX’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, RPTX is a better buy in the short-term than ALNY.

Price Growth

ALNY (@Biotechnology) experienced а -4.33% price change this week, while RPTX (@Biotechnology) price change was +0.58% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.35%. For the same industry, the average monthly price growth was +5.87%, and the average quarterly price growth was +34.62%.

Reported Earning Dates

ALNY is expected to report earnings on Oct 23, 2025.

RPTX is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Biotechnology (+1.35% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ALNY($60.5B) has a higher market cap than RPTX($75.8M). ALNY YTD gains are higher at: 96.014 vs. RPTX (32.824). RPTX has higher annual earnings (EBITDA): -110.47M vs. ALNY (-170.84M). ALNY has more cash in the bank: 2.86B vs. RPTX (109M). RPTX has less debt than ALNY: RPTX (649K) vs ALNY (1.3B). ALNY has higher revenues than RPTX: ALNY (2.46B) vs RPTX (250K).
ALNYRPTXALNY / RPTX
Capitalization60.5B75.8M79,815%
EBITDA-170.84M-110.47M155%
Gain YTD96.01432.824293%
P/E RatioN/AN/A-
Revenue2.46B250K984,800%
Total Cash2.86B109M2,622%
Total Debt1.3B649K199,846%
FUNDAMENTALS RATINGS
ALNY: Fundamental Ratings
ALNY
OUTLOOK RATING
1..100
80
VALUATION
overvalued / fair valued / undervalued
1..100
96
Overvalued
PROFIT vs RISK RATING
1..100
8
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
38
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ALNYRPTX
RSI
ODDS (%)
Bearish Trend 2 days ago
69%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
73%
Bearish Trend 2 days ago
84%
Momentum
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
81%
MACD
ODDS (%)
Bearish Trend 2 days ago
70%
Bullish Trend 2 days ago
83%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
64%
Bullish Trend 2 days ago
86%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
84%
Advances
ODDS (%)
Bullish Trend 9 days ago
76%
Bullish Trend 7 days ago
82%
Declines
ODDS (%)
Bearish Trend 3 days ago
64%
Bearish Trend about 1 month ago
88%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
87%
View a ticker or compare two or three
Interact to see
Advertisement
ALNY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RPTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
OBYCF17.500.20
+1.16%
Obayashi Corp.
DVHGF0.18N/A
N/A
Devonian Health Group Inc.
HAUP0.01N/A
N/A
Hauppauge Digital, Inc.
MLTTY7.69N/A
N/A
Multiplan Empreendimentos Imobiliarios SA
AUDGF2.95-0.05
-1.67%
Audinate Group LTD.

RPTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, RPTX has been loosely correlated with INO. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if RPTX jumps, then INO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RPTX
1D Price
Change %
RPTX100%
-1.42%
INO - RPTX
51%
Loosely correlated
N/A
BCYC - RPTX
51%
Loosely correlated
+1.31%
CADL - RPTX
43%
Loosely correlated
N/A
ALNY - RPTX
38%
Loosely correlated
+0.02%
AXON - RPTX
37%
Loosely correlated
-1.33%
More